Novel CD20 monoclonal antibodies for lymphoma therapy

Rituximab (RTX), a monoclonal antibody (mAb) against CD20, has been widely used for lymphoma therapy. RTX in combination with cyclophosphamide /doxorubicin /vincristine /prednisone (R-CHOP) remains the standard frontline regimen for diffuse large B-cell lymphoma. However, suboptimal response and /or...

Descripción completa

Detalles Bibliográficos
Autores principales: Cang, Shundong, Mukhi, Nikhil, Wang, Kemeng, Liu, Delong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479003/
https://www.ncbi.nlm.nih.gov/pubmed/23057966
http://dx.doi.org/10.1186/1756-8722-5-64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479003/
https://www.ncbi.nlm.nih.gov/pubmed/23057966
http://dx.doi.org/10.1186/1756-8722-5-64

Ejemplares similares